Top Markets
#1 Purr Purr +32.88%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +32.33%
#3 OriginTrail OriginTrail +22.45%
#4 ApeX ApeX +19.17%
#5 UnifAI Network UnifAI Network +18.04%
#6 Unit Plasma Unit Plasma +17.45%
#7 Plasma Plasma +17.45%
#8 Morpho Morpho +16.16%
#9 Pendle Pendle +15.57%
#10 Non-Playable Coin Non-Playable Coin +15.38%
Coin of the day
Purr Purr
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Sudarshan Pharma Industries Ltd. Sudarshan Pharma Industries Ltd.

Sudarshan Pharma Industries Ltd.

SUDARSHAN
Classement en actions #21543
Sudarshan Pharma Industries Ltd. operates as a supplier of specialty chemicals,... Sudarshan Pharma Industries Ltd. operates as a supplier of specialty chemicals, intermediates, and active pharmaceutical ingredients. The company strategically sources its products externally to cater to clients both within India and internationally. Additionally, the firm is active in contract manufacturing and provides outsourced generic pharmaceutical formulations and various medicines. These are supplied to a broad spectrum of clients, including healthcare institutions, governmental agencies, non-profit organizations, and hospitals. Established on July 23, 2008, Sudarshan Pharma maintains its corporate headquarters in Mumbai, India.
Prix de l'action
$0.42123944
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$105.17M
Changement (1 jour)
-0.57%
Changement (1 an)
5.80%
Pays
IN
Échange Sudarshan Pharma Industries Ltd. (SUDARSHAN)

Catégorie

Healthcare
Ratio P/S pour Sudarshan Pharma Industries Ltd. (SUDARSHAN)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Sudarshan Pharma Industries Ltd., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Sudarshan Pharma Industries Ltd. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
10.24 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
14.89 -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT